All News

Pharmacists respond to questions about birth control.

Certain populations have been found to have differing prognoses, such as African American patients, who have an earlier onset of disease with a higher likelihood of an aggressive tumor type and shorter survival.

Asian Americans often develop the disease at a normal weight, which would be overlooked by current screening guidelines, investigators say.

The drug from AstraZeneca and Ionis Pharmaceuticals demonstrates a sustained benefit through 66 weeks for those with hereditary transthyretin-mediated amyloid polyneuropathy.

Experts note that pharmacists are well positioned to play a key role in precision oncology and molecular tumor boards.

CGM devices can also help individuals with diabetes make more informed decisions about their diet, exercise, and medication management, leading to improved overall health outcomes.

Legal expert breaks down the history of power between federal v. state law and why Dobbs v. Jackson has caused such a stir for the pharmaceutical community.

Historically, there are many hard-to-treat mutations of non-small cell lung cancer.

The company announced the initiation of the EVERGREEN study, which was aimed to evaluate the efficacy, safety, and immunogenicity of the investigational respiratory syncytial virus vaccine, in 2021.

Pharmacists need food too, you know.

This month's guest is Jennifer Lind, PharmD, MPH, MBA, a public health pharmacists, epidemiologist in the Medication Safety Program at the CDC, and commander in the United States Public Health Service Commissioned Corps.

Barbara Kirkaldy, BS, CPhT, pharmacy regulatory specialist at Novant Health, discusses her role in the pharmacy and alternative career paths for pharmacy technicians.

Authorized for use in professional point-of-care settings, the nucleic acid amplification diagnostic tool delivers results in 25 minutes.

Regeneron and Sanofi’s Dupilumab is the first biologic to demonstrate a clinically meaningful and statistically significant reduction in exacerbations compared with the placebo.

The implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.

Studies show that patients who are introduced to patient support programs through digital platforms are more likely to use support services.

Quantitative polymerase chain reaction methods that are validated to determine bacterial load are important for assessing the impact of vaccines in public health programs.

Products include multivitamin gummies and a superfood supplement.

Eflapegrastim-xnst subcutaneous injection (Rolvedon) reduces infections related to febrile neutropenia in adults with nonmyeloid malignant tumors who are being treated with certain anticancer drugs.

President (2022 to 2023) of the Hematology Oncology Pharmacists Association (HOPA) highlights the many ways that hematology/oncology pharmacists can collaborate with care teams to improve access to care at HOPA Annual Conference 2023 in Phoenix, Arizona from March 29 to April 1.

FDA action allows for OTC naloxone (Narcan) to be sold directly to consumers in pharmacies, convenience stores, grocery stores, gas stations, and online.

Follow Pharmacy Times®’ live coverage of the Hematology/Oncology Pharmacy Association (HOPA) Annual Conference in Phoenix, Arizona from March 29 to April 1, 2023.

The main cause of C. diff infection remains antibiotic use and overuse.

Improvements in progression-free survival were seen in patients with advanced or recurrent endometrial carcinoma regardless of mismatch repair status.

Increased risk for severe disease in individuals with SUD could be from co-occurring medical conditions, investigators from Boston Medical Center say.

Muneeb Shah, DO, dermatologist and partner at PC Dermatology PLLC, and Reid Maclellan, MD, founder of Cortina Health Inc also discuss the role technology and social media play in health care education.

Data indicated that waist-to-height ratio is a better indicator of outcomes in patients with HF than body mass index.

Removing the word ‘risk’ from discussions of HIV PrEP and focusing more on environment and empowerment concerns are beneficial in this patient population.